Founders, Executive Team, and Advisors are recognized scientific and clinical pioneers in the fields of immunology and cardiology Series A financing co-led by ARCH Venture Partners and Deerfield Management with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others PALO ALTO, Calif. – Bitterroot Bio, a biotechnology company focused on developing novel immunotherapies […]